Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 25, 2020	Mar. 27, 2019
Cash flows from operating activities:
Net income	$ 9,013	$ 15,490
Adjustments to reconcile net income to cash flows provided by operating activities:
Depreciation and amortization	4,146	6,233
Operating (gains), losses and other charges, net	1,473	(8,935)
Amortization of deferred financing costs	152	152
Gains on investments	(116)	(39)
Losses (gains) on early extinguishments of debt and leases	28	(74)
Deferred income tax (benefit) expense	(2,577)	1,476
Share-based compensation (benefit) expense	(1,537)	2,253
Changes in assets and liabilities:
Receivables	15,815	7,428
Inventories	(4)	121
Other current assets	4,111	2,904
Other assets	1,578	(1,355)
Operating lease assets/liabilities	(18)	(234)
Accounts payable	(7,465)	(1,471)
Accrued salaries and vacations	(12,783)	(6,439)
Accrued taxes	(971)	(494)
Other accrued liabilities	(6,337)	(5,499)
Other noncurrent liabilities	(2,607)	951
Net cash flows provided by operating activities	1,901	12,468
Cash flows from investing activities:
Capital expenditures	(2,818)	(3,109)
Acquisition of restaurants and real estate	0	(4,706)
(Costs) proceeds from sales of restaurants, real estate and other assets	(35)	7,914
Investment purchases	(1,400)	(1,300)
Collections on notes receivable	505	425
Issuance of notes receivable	(408)	(571)
Net cash flows used in investing activities	(4,156)	(1,347)
Cash flows from financing activities:
Revolver borrowings	102,500	28,500
Revolver payments	(24,500)	(31,500)
Long-term debt payments	(406)	(795)
Proceeds from exercise of stock options	0	107
Tax withholding on share-based payments	(3,036)	(3,178)
Purchase of treasury stock	(36,008)	(8,089)
Net bank overdrafts	(449)	705
Net cash flows provided by (used in) financing activities	38,101	(14,250)
Increase (decrease) in cash and cash equivalents	35,846	(3,129)
Cash and cash equivalents at beginning of period	3,372	5,026
Cash and cash equivalents at end of period	$ 39,218	$ 1,897